Markets:

Overview

News

Currencies

International

Treasuries

Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

15.47 -1.08 (-6.50%)

Streaming Delayed Price Updated: 3:28 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Tonix Pharmaceuticals Holding Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Tonix Pharmaceuticals To Meet With FDA In 2026 To Advance Experimental Lyme Disease Prevention Drug ↗

December 29, 2025

The company also announced the pricing of a $20 million registered direct offering.

Via Stocktwits

Tonix Pharmaceuticals Stock Jumps Into Retail Spotlight After $25M Buyback Boost — Traders See ‘Blueprint For Rerating’ ↗

November 18, 2025

Retail traders pointed to the expanded buyback authorization as a sign of management confidence, framing it as a potential catalyst for renewed valuation upside.

Via Stocktwits

Why Did TNXP Stock Jump 10% Today? ↗

November 17, 2025

Tonix Pharmaceuticals on Monday announced the launch of its new drug to treat Fibromyalgia.

Via Stocktwits

Why Tonix Pharmaceuticals (TNXP) Stock Jumped Monday Morning ↗

November 17, 2025

Tonix Pharmaceuticals shares are rising Monday morning after the company announced the U.S. commercial availability of its new drug, TONMYA.

Via Benzinga

TONIX PHARMACEUTICALS HOLDIN (NASDAQ:TNXP) Surges 77% on Q3 Earnings Beat and Key Drug Launch ↗

November 10, 2025

Tonix Pharmaceuticals stock surged 77% after Q3 earnings beat estimates and confirming the November launch of its new fibromyalgia drug, Tonmya.

Via Chartmill

Topics Earnings

This Pharma Stock Shot Up 4% Pre-Market After FDA Approval For Drug, Retail’s Super Bullish But Believes ‘This Is A Marathon, Not A Sprint’ ↗

August 18, 2025

Via Stocktwits

Tonix Pharma Scores Best Day Since March On Hopes For First New Fibromyalgia Drug Approval in 16 Years; Retail’s Optimistic ↗

August 12, 2025

Via Stocktwits

Eledon Pharmaceuticals (ELDN) Plummets Nearly 50% Amidst Mixed Phase 2 Trial Results, Sparking Investor Concern

November 10, 2025

San Diego, CA – November 10, 2025 – Eledon Pharmaceuticals (NASDAQ: ELDN) witnessed a dramatic collapse in its stock price, shedding nearly 50% of its value following the announcement of mixed results...

Via MarketMinute

Fabrinet, Adecoagro And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

August 19, 2025

Via Benzinga

What's going on in today's session ↗

August 18, 2025

Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August ↗

August 18, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 18, 2025

Via Benzinga

Monday's session: top gainers and losers ↗

August 18, 2025

Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

August 18, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

Tonix Pharma's Drug Gets FDA Nod For Chronic Pain Condition, First New Therapy In Over 15 Years ↗

August 18, 2025

FDA approves Tonmya, a non-opioid fibromyalgia therapy from Tonix, with strong trial data and U.S. launch expected in late 2025.

Via Benzinga

Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket ↗

August 18, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 15, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

August 15, 2025

As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket ↗

August 15, 2025

Via Benzinga

What's Going On With Tonix Pharmaceuticals (TNXP) Stock? ↗

August 14, 2025

Shares of Tonix Pharmaceuticals have rallied 30% over the past five sessions. Investors are anticipating a key catalyst for the company.

Via Benzinga

Why Tonix Pharmaceuticals (TNXP) Stock Is Climbing This Week ↗

August 13, 2025

Shares of Tonix Pharmaceuticals are building on recent gains. The stock is trading higher as investor focus intensifies on a key, upcoming catalyst.

Via Benzinga

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

August 12, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

Mercury Systems Posts Better-Than-Expected Earnings, Joins Green Dot, Arcturus Therapeutics And Other Big Stocks Moving Higher On Tuesday ↗

August 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 12, 2025

Via Benzinga

Tonix Pharmaceuticals (TNXP) Stock Surges On Q2 Earnings Beat And Upcoming FDA Catalyst ↗

August 12, 2025

Shares of Tonix Pharmaceuticals are trading sharply higher Tuesday morning. The stock is gaining following the release of the company's Q2 financial results and operational update.

Via Benzinga

Topics Earnings

Tonix Pharmaceuticals (TNXP) Files To Raise $500 Million, Shares Tumble ↗

June 12, 2025

Tonix Pharmaceuticals has filed a registration statement to sell up to $500 million in securities. The company's lead drug candidate is for the management of fibromyalgia pain.

Via Benzinga

Oxford Industries, GameStop, Boeing And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

June 12, 2025

Via Benzinga

Wondering what's happening in today's pre-market session? ↗

June 12, 2025

Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 12, 2025

Via Benzinga

Tonix Pharma Stock Plunges 20% Pre-market On Share Sale Announcement, But Retail’s Not Pessimistic ↗

June 12, 2025

The proceeds from the purchase agreement are expected to be used for working capital and general corporate purposes.

Via Stocktwits

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.